Immunocore attracts Lilly in co-co deal

Immunocore has locked in its fourth big pharma partner in just over a year – Lilly. Unlike previous deals, Immunocore has managed to retain some co-discovery and co-development rights, making it unique among the company's collaborations. This is likely to be the UK biotech's last deal for a while.